Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Ulrik Tarp"'
Autor:
Gitte Lund Christensen, Trine W. Jensen, Michael Sejer Hansen, Kim Hørslev-Petersen, Lars Hyldstrup, Bo Abrahamsen, Bente Langdahl, Bo Zerahn, Jan Pødenphanth, Kristian Stengaard-Petersen, Peter Junker, Mikkel Østergaard, Tine Lottenburger, Torkell Juulsgaard Ellingsen, Lis Smedegaard Andersen, Ib Tønder Hansen, Henrik Skjødt, Jens K. Pedersen, Anders Jørgen Svendsen, Ulrik Tarp, Hanne M. Lindegaard, Merete Lund Hetland, Niklas Rye Jørgensen
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100364- (2020)
Externí odkaz:
https://doaj.org/article/e6e683259bc54eee9840be6ef98e057d
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Objective Little is known about the prognosis of infections in patients with ankylosing spondylitis (AS) compared with patients without AS. The purpose of this study was to examine whether AS is associated with poorer outcomes in patients who are hos
Externí odkaz:
https://doaj.org/article/312126b4d4494fdd8eeed1a1b3e4a521
Autor:
Christina Brock, Ulrik Tarp, Bent Deleuran, Liao D, Birgitte Brock, Stengaard-Pedersen C, Pfeiffer-Jensen M, Venborg J
Objectives: We hypothesized that Therapeutic Drug Monitoring (TDM) decreased drug consumption or accelerated switch of biologics in chronic arthritis patients on TNF-alpha inhibiting (TNFi)-therapy. Primary outcome was dose reduction, secondary outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6daa1906c8033e1dee0ac4b23e864d7d
https://doi.org/10.22541/au.162328947.71637310/v1
https://doi.org/10.22541/au.162328947.71637310/v1
Autor:
Mogens Pfeiffer-Jensen, Donghua Liao, Ulrik Tarp, Bent Deleuran, Kristian Steengaard-Pedersen, Jacob Venborg, Birgitte Brock, Christina Brock
Publikováno v:
SSRN Electronic Journal.
Autor:
Bo Zerahn, Torkell Ellingsen, Ulrik Tarp, Mikkel Østergaard, Peter Junker, Tine Lottenburger, Bente L. Langdahl, Trine W. Jensen, Jens Kristian Pedersen, Niklas Rye Jørgensen, Hanne Merete Lindegaard, Lis Smedegaard Andersen, Michael Sejer Hansen, Anders Jørgen Svendsen, Jan Pødenphanth, Henrik Skjødt, K Stengaard-Petersen, Kim Hørslev-Petersen, Gitte Lund Christensen, Lars Hyldstrup, Bo Abrahamsen, Merete Lund Hetland, Ib Tønder Hansen
Publikováno v:
the Cimestra study group 2020, ' Rheumatoid arthritis treatment associated changes in circulating bone-turnover markers ', Bone Reports, vol. 13, no. Suppl., P010, pp. 2-3 . https://doi.org/10.1016/j.bonr.2020.100364
Bone Reports, Vol 13, Iss, Pp 100364-(2020)
Bone Reports, Vol 13, Iss, Pp 100364-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f75752bce8aff19956fcd024d11980c
https://portal.findresearcher.sdu.dk/da/publications/e378a2c1-1746-4787-8ffd-310cd2119fac
https://portal.findresearcher.sdu.dk/da/publications/e378a2c1-1746-4787-8ffd-310cd2119fac
Autor:
Saida Farah Issa, Kirsten Junker, Mikkel Østergaard, Kim Hørslev-Petersen, Bo Ejbjerg, Torkell Ellingsen, Peter Junker, Tine Lottenburger, Jens Kristian Pedersen, Ulrik Tarp, Anders Jørgen Svendsen, Hanne Merete Lindegaard, Anne Friesgaard Christensen, Merete Lund Hetland, Kristian Stengaard-Pedersen
Publikováno v:
Issa, S F, Christensen, A F, Lindegaard, H M, Hetland, M L, Hørslev-Petersen, K, Stengaard-Pedersen, K, Ejbjerg, B J, Lottenburger, T, Ellingsen, T, Pedersen, J K, Junker, K, Svendsen, A, Tarp, U, Østergaard, M & Junker, P 2017, ' Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity ', Scandinavian Journal of Immunology, vol. 86, no. 6, pp. 471–478 . https://doi.org/10.1111/sji.12619
Issa, S F, Christensen, A F, Lindegaard, H M, Hetland, M L, Horslev-Petersen, K, Stengaard-Pedersen, K, Ejbjerg, B J, Lottenburger, T, Ellingsen, T, Pedersen, J K, Junker, K, Svendsen, A, Tarp, U, Ostergaard, M & Junker, P 2017, ' Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity ', Scandinavian Journal of Immunology, vol. 86, no. 6, pp. 471-478 . https://doi.org/10.1111/sji.12619
Issa, S F, Christensen, A F, Lindegaard, H M, Hetland, M L, Horslev-Petersen, K, Stengaard-Pedersen, K, Ejbjerg, B J, Lottenburger, T, Ellingsen, T, Pedersen, J K, Junker, K, Svendsen, A, Tarp, U, Ostergaard, M & Junker, P 2017, ' Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity ', Scandinavian Journal of Immunology, vol. 86, no. 6, pp. 471-478 . https://doi.org/10.1111/sji.12619
Galectin-3 has been suggested as a pro-inflammatory mediator in animal arthritis and rheumatoid arthritis (RA). We aimed to study the serum level of galectin-3 in patients with newly diagnosed RA and associations with disease profile, Magnetic Resona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ca13040aa3b7f8f7125ea92f596f41
https://portal.findresearcher.sdu.dk/da/publications/e93b70c8-2af7-44f9-b86c-eaa202abef31
https://portal.findresearcher.sdu.dk/da/publications/e93b70c8-2af7-44f9-b86c-eaa202abef31
Autor:
Annette de Thurah, Thomas Maribo, Ulrik Tarp, Kristian Stengaard-Pedersen, Ulrich Fredberg, Liv Marit Valen Schougaard, Kirsten Lomborg, Mogens Pfeiffer-Jensen, Trine Bay Laurberg, Mette Bjørndal Axelsen, Niels Henrik Hjollund
Publikováno v:
Thurah, A D, Stengaard-Pedersen, K, Axelsen, M, Fredberg, U, Schougaard, L M V, Hjollund, N H I, Pfeiffer-Jensen, M, Laurberg, T B, Tarp, U, Lomborg, K & Maribo, T 2018, ' Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis : Results of a Randomized Controlled Trial ', Arthritis Care & Research, vol. 70, no. 3, pp. 353–360 . https://doi.org/10.1002/acr.23280
Thurah, A D, Steengaard-Pedersen, K, Axelsen, M, Fredberg, U, Schougaard, L M V, Hjøllund, N H I, Jensen, M P, Laurberg, T B, Tarp, U, Lomborg, K & Maribo, T 2018, ' Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis : Results of a Randomized Controlled Trial ', Arthritis Care & Research, vol. 70, no. 3, pp. 353-360 . https://doi.org/10.1002/acr.23280
Thurah, A D, Steengaard-Pedersen, K, Axelsen, M, Fredberg, U, Schougaard, L M V, Hjøllund, N H I, Jensen, M P, Laurberg, T B, Tarp, U, Lomborg, K & Maribo, T 2018, ' Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis : Results of a Randomized Controlled Trial ', Arthritis Care & Research, vol. 70, no. 3, pp. 353-360 . https://doi.org/10.1002/acr.23280
Objective To test the effect of patient-reported outcome (PRO)–based tele-health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele-health followup performed by rheumatologist
Autor:
Thomas Adelsten, Ulrik Tarp, Merete Lund Hetland, Mette Holland-Fischer, Regitse Christensen, Pil Højgaard, Christine Nilsson, Bente Glintborg, Emina Omerovic, Torben Højland Hansen, Lene Dreyer, René Østgård, Jørgen Arendt Jensen, Martin H Petersen, Bjarne Andersen, Anne Gitte Loft, Philip Rask Lage-Hansen
Publikováno v:
Højgaard, P, Glintborg, B, Hetland, M L, Hansen, T H, Lage-Hansen, P R, Petersen, M H, Holland-Fischer, M, Nilsson, C, Loft, A G, Andersen, B N, Adelsten, T, Jensen, J, Omerovic, E, Christensen, R, Tarp, U, Ostgård, R & Dreyer, L 2015, ' Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis : Results from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 74, no. 12, pp. 2130-2136 . https://doi.org/10.1136/annrheumdis-2014-205389
Højgaard, P, Glintborg, B, Hetland, M L, Hansen, T H, Lage-Hansen, P R, Petersen, M H, Holland-Fischer, M, Nilsson, C, Loft, A G R, Andersen, B N, Adelsten, T, Jensen, J, Omerovic, E, Christensen, R, Tarp, U, Ostgård, R & Dreyer, L 2014, ' Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis : results from the DANBIO registry ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2014-205389
Højgaard, P, Glintborg, B, Hetland, M L, Hansen, T H, Rask Lage-Hansen, P, Petersen, M H, Holland-Fischer, M, Nilsson, C, Loft, A G, Andersen, B N, Adelsten, T, Jensen, J, Omerovic, E, Christensen, R, Tarp, U, Østgård, R & Dreyer, L 2015, ' Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis : results from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 74, no. 12, pp. 2130-2136 . https://doi.org/10.1136/annrheumdis-2014-205389
Højgaard, P, Glintborg, B, Hetland, M L, Hansen, T H, Lage-Hansen, P R, Petersen, M H, Holland-Fischer, M, Nilsson, C, Loft, A G R, Andersen, B N, Adelsten, T, Jensen, J, Omerovic, E, Christensen, R, Tarp, U, Ostgård, R & Dreyer, L 2014, ' Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis : results from the DANBIO registry ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2014-205389
Højgaard, P, Glintborg, B, Hetland, M L, Hansen, T H, Rask Lage-Hansen, P, Petersen, M H, Holland-Fischer, M, Nilsson, C, Loft, A G, Andersen, B N, Adelsten, T, Jensen, J, Omerovic, E, Christensen, R, Tarp, U, Østgård, R & Dreyer, L 2015, ' Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis : results from the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 74, no. 12, pp. 2130-2136 . https://doi.org/10.1136/annrheumdis-2014-205389
ObjectivesTo investigate the association between tobacco smoking and disease activity, treatment adherence and treatment responses among patients with psoriatic arthritis (PsA) initiating the first tumour necrosis factor α inhibitor therapy (TNFi) i
Autor:
Katerina Chatzidionysiou, Ulrik Tarp, Elisabeth Lie, I. Ancuta, R.F. Vollenhoven, Dan Nordström, Galina Lukina, Matija Tomšič, Karel Pavelka, J. Gomez-Reino, Cem Gabay, Evgeny Nasonov, Helena Canhão, Merete Lund Hetland, P.L.C.M. Riel, T.K. Kvien
Publikováno v:
Chatzidionysiou, K, Lie, E, Nasonov, E, Lukina, G, Hetland, M L, Tarp, U, Ancuta, I, Pavelka, K, Nordström, D C, Gabay, C, Canhão, H, Tomsic, M, van Riel, P L C M, Gomez-Reino, J, Kvien, T K & van Vollenhoven, R F 2016, ' Erratum to : Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration ', Arthritis Research & Therapy, vol. 18, no. 1, pp. 144 . https://doi.org/10.1186/s13075-016-1048-4
Arthritis Research & Therapy
Arthritis Research & Therapy, 18(1). BioMed Central
Arthritis Research & Therapy
Arthritis Research & Therapy, 18(1). BioMed Central
The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The purpose of this study was to compare the effectiveness of the regular and low doses given as fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2af04333139cac9f920b9cd3bab5cc
https://research.vumc.nl/en/publications/31fe54b4-6846-45ce-ad78-045e9f6e072e
https://research.vumc.nl/en/publications/31fe54b4-6846-45ce-ad78-045e9f6e072e
Autor:
Signe Møller-Bisgaard, Iris Eshed, Trine Torfing, Aage Vestergaard, Peter Junker, L. S. Andersen, Jan Pødenphant, Ulrik Tarp, Kim Hørslev-Petersen, Niels Steen Krogh, Merete Lund Hetland, Henrik S. Thomsen, Torkell Ellingsen, Hanne Merete Lindegaard, Mikkel Østergaard, Jens Kristian Pedersen, Bo Ejbjerg, Lars G. Hanson, Ib Hansen, Henrik Skjødt, Kristian Stengaard-Pedersen, A G Jurik, Tine Lottenburger, Daniel Glinatsi, Anders Jørgen Svendsen
Publikováno v:
Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, D & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550
Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, M & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550
Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, M & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550
OBJECTIVES: To investigate whether a treat-to-target strategy based on methotrexate (MTX) and intra-articular (IA) betamethasone suppresses magnetic resonance imaging (MRI)-determined measures of disease activity and reduces joint destruction in earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb93c7eb3f367eb6e49deac4bedd859d